MedTech Industry Rejects USTR Claims, Urges GTE Policy Revision
India’s MedTech industry has strongly refuted the claims made by the United States Trade Representative (USTR) in its 2025 National…
MedTech Industry
Read More
June 21, 2026
- Centre Bans 16 Fixed-Dose Combination Drugs, Citing Safety and Lack of Therapeutic Value
- NEET 2026 Re-exam: NMC asks Medical Colleges to Stay Alert, Restrict Student leave on June 20-21
- Hospitals May Soon Be Allowed to Import Advanced Medical Devices Directly
- Centre Recognizes AMTZ as National Biomedical Skill-Awarding Body